Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial
- PMID: 29946003
- DOI: 10.1183/13993003.00555-2018
Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial
Conflict of interest statement
Conflict of interest: N.J. Brendish has been an investigator and recruited patients into clinical trials of antivirals sponsored by Gilead and Janssen. Conflict of interest: T.W. Clark reports personal fees for consultancy work from Roche, speaker fees, travel expenses, equipment and consumables for purposes of research from BioFire LLC, outside the submitted work. He has been a principal investigator or chief investigator for industry sponsored trials of antivirals (Gilead, Janssen) and has been an investigator and recruited patients into clinical trials sponsored by Novartis, Baxter and GSK.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical